Laduviglusib (CHIR-99021)是一种有效、选择性且具有口服活性的 GSK-3α/β 抑制剂，可用作细胞疗法中的辅助试剂。

SB-216763是一种高效、选择性和ATP竞争性的GSK-3抑制剂，对GSK-3α和GSK-3β的IC50均为34.3 nM。

CHIR-98014 (CT98014) is highly selective aminopyrimidine-derivatived inhibitor of GSK-3 with IC50 of 650nM and 580nM for GSK-3 and GSK-3(measured by kinase assays), respectively, and exhibits >1000-fold selectivity for GSK-3 over closely related kinases, such as cdc2.

SB-415286 is an ATP-competitive inhibitor of GSK3α/GSK3β with IC50 of 78 nM and Ki of 31 nM.

AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor of GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively, shows > 14-fold selectivity against CDK2, CDK5, CDK1 and Erk2.

LY2090314是一种高效的糖原合成酶激酶-3（GSK-3）抑制剂，对GSK-3α和GSK-3β的IC50值分别为1.5 nM和0.9 nM。

BIO-acetoxime is an inhibitor of GSK3α and GSK3β with IC50 of 10 nM.